Canaccord Genuity Maintains Buy on WAVE Life Sciences, Raises Price Target to $52
Wave Life Sciences Ltd.
Wave Life Sciences Ltd. WVE | 0.00 |
Canaccord Genuity analyst Whitney Ijem maintains WAVE Life Sciences (NASDAQ:
WVE) with a Buy and raises the price target from $43 to $52.
